{"id":"NCT01701401","sponsor":"Gilead Sciences","briefTitle":"Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV","officialTitle":"A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5885 Fixed-Dose Combination (FDC) +/- Ribavirin for 12 and 24 Weeks in Treatment-Naive Subjects With Chronic Genotype 1 HCV Infection.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-09","primaryCompletion":"2014-03","completion":"2014-04","firstPosted":"2012-10-05","resultsPosted":"2015-03-27","lastUpdate":"2018-11-16"},"enrollment":870,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Virus"],"interventions":[{"type":"DRUG","name":"LDV/SOF","otherNames":["HarvoniÂ®","GS-5885/GS-7977"]},{"type":"DRUG","name":"RBV","otherNames":[]}],"arms":[{"label":"LDV/SOF 12 weeks","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV 12 weeks","type":"EXPERIMENTAL"},{"label":"LDV/SOF 24 weeks","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV 24 weeks","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety, tolerability, and antiviral efficacy of ledipasvir (LDV)/sofosbuvir (SOF) fixed-dose combination (FDC) tablets with or without ribavirin (RBV) administered for 12 and 24 weeks in treatment-naive subjects with chronic genotype 1 HCV infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Study Drug (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"LDV/SOF 12 Weeks","deltaMin":98.6,"sd":null},{"arm":"LDV/SOF+RBV 12 Weeks","deltaMin":97.2,"sd":null},{"arm":"LDV/SOF 24 Weeks","deltaMin":98.2,"sd":null},{"arm":"LDV/SOF+RBV 24 Weeks","deltaMin":99.1,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.001"},{"comp":"OG001","p":"<0.001"},{"comp":"OG002","p":"<0.001"},{"comp":"OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":88,"countries":["United States","France","Germany","Italy","Puerto Rico","Spain","United Kingdom"]},"refs":{"pmids":["27553375","26280786","24725239"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":214},"commonTop":["Fatigue","Headache","Insomnia","Nausea","Asthenia"]}}